A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)
Clinical trial NCT00345163 · COMPLETED
Trial details
- NCT number
- NCT00345163
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2007-09-01
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.